Uncovering the molecular mechanism of Mume Fructus in treatment of Sjögren's syndrome

被引:0
|
作者
Sun, Zhongli [1 ]
Deng, Lilin [1 ]
Xu, Zhoujie [1 ]
Yang, Kun [1 ]
Yu, Penglong [1 ]
机构
[1] Chongqing Three Gorges Med Coll, 366 Tianxing Rd, Chongqing 404120, Peoples R China
关键词
molecular docking; Mume Fructus; network pharmacology; Sj & ouml; gren's syndrome; PRIMARY SJOGRENS-SYNDROME; DISEASE; RISK; INHIBITION; ACTIVATION; EXPRESSION; QUERCETIN; HHV-8; CELLS;
D O I
10.1097/MD.0000000000038085
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:Modern medicine has no cure for the xerostomia caused by the early onset of Sj & ouml;gren's syndrome. Mume Fructus is a common Chinese herbal medicine used to relieve xerostomia. However, the molecular mechanisms of the effects of Mume Fructus are unknown. In this study, network pharmacology and molecular docking were used to investigate the mechanisms of action of Mume Fructus on Sj & ouml;gren's syndrome.Materials and method:The Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform database was used to identify the active components and targets of Mume Fructus, and the UniProt database was used to identify the genes encoding these targets. SS-related targets were also identified from the GeneCards and OMIM databases. By finding the intersection of the targets of the compounds and the targets of Sj & ouml;gren's syndrome, the predicted targets of Mume Fructus in the treatment of Sj & ouml;gren's syndrome were obtained. Further investigation of the active compounds and their targets was carried out by constructing a network of "medicine-candidate compound-target-disease" using Cytoscape 3.7.2, the Protein-Protein Interaction network using the STRING database and Cytoscape 3.7.2, and key targets were identified by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis on R software. Finally, molecular docking was used to verify the affinity of the candidate compounds to the key targets.Results:Quercetin, beta-sitosterol, and kaempferol in Mume Fructus interact with AKT1, IL-6, IL-1B, JUN, CASP3, and MAPK8. These results suggest that Mume Fructus exerts its therapeutic effects on the peripheral gland injury of Sj & ouml;gren's syndrome and its secondary cardiovascular disease and tumorigenesis through anti-inflammatory, anti-oxidant, and anti-tumor pathways.Conclusion:With network pharmacology, this study systematically identified the main active components, targets, and specific mechanisms of the therapeutic effects of Mume Fructus on Sj & ouml;gren's syndrome, providing both a theoretical basis and research direction for further investigations on Mume Fructus.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Network pharmacology and molecular docking analysis on the mechanism of Tripterygium wilfordii Hook in the treatment of Sjögren syndrome
    Wang, Zelin
    Xu, Yanan
    Liang, Shufen
    MEDICINE, 2024, 103 (14)
  • [2] Update on Sjögren's syndrome Diagnostics, treatment, and challenges
    Zehrfeld, Nadine
    Witte, Torsten
    Ernst, Diana
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2024, 83 (03): : 217 - 228
  • [3] Update on Sjögren's Syndrome: Diagnostics & Therapy
    Zehrfeld, Nadine
    Witte, Torsten
    Ernst, Diana
    AKTUELLE RHEUMATOLOGIE, 2024, 49 (03) : 168 - 177
  • [4] Uncovering potential new biomarkers and immune infiltration characteristics in primary Sjögren's syndrome by integrated bioinformatics analysis
    Zhang, Naidan
    Ji, Chaixia
    Bao, Xiao
    Peng, Xinyin
    Tang, Maoju
    Yuan, Chengliang
    MEDICINE, 2023, 102 (41) : E35534
  • [5] Decoding Hippophae rhamnoides? action of mechanism in Sj?gren?s syndrome: A network pharmacology and molecular docking study
    Xia, Lu-yun
    Luo, Zheng
    Xu, Han-piao
    Liu, Liu
    Huai, Wen-ying
    Xia, Jun
    Yin, Qiao-zhi
    Zhang, Tian-e
    Chen, Yun-hui
    QUALITY ASSURANCE AND SAFETY OF CROPS & FOODS, 2023, 15 (01) : 207 - 250
  • [6] Loss of tricellular tight junction tricellulin leads to hyposalivation in Sjögren's syndrome
    Mao, Xiangdi
    Li, Haibing
    Min, Sainan
    Su, Jiazeng
    Wei, Pan
    Zhang, Yan
    He, Qihua
    Wu, Liling
    Yu, Guangyan
    Cong, Xin
    INTERNATIONAL JOURNAL OF ORAL SCIENCE, 2025, 17 (01)
  • [7] Update on the pathophysiology and treatment of primary Sjögren syndrome
    Baldini, Chiara
    Fulvio, Giovanni
    La Rocca, Gaetano
    Ferro, Francesco
    NATURE REVIEWS RHEUMATOLOGY, 2024, 20 (08) : 473 - 491
  • [8] Sjögren's syndrome and psoriasis: a two-sample Mendelian randomization study
    Dai, Bingqing
    Xin, Yu
    Jun, Wang
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [9] Ovarian reserve in patients with Sjögren's syndrome: a cross-sectional study
    Mandosi, Chiara
    Matys, Viviana
    Deroma, Marianna
    Del Negro, Valentina
    Merlino, Lucia
    Mariani, Marianna
    Priori, Roberta
    Ciminello, Enrico
    Anastasi, Emanuela
    Porpora, Maria Grazia
    Piccioni, Maria Grazia
    CLINICAL RHEUMATOLOGY, 2024, : 319 - 325
  • [10] Chemokines and lymphocyte homing in Sjögren's syndrome
    Liao, Jiahe
    Yu, Xinbo
    Huang, Ziwei
    He, Qian
    Yang, Jianying
    Zhang, Yan
    Chen, Jiaqi
    Song, Weijiang
    Luo, Jing
    Tao, Qingwen
    FRONTIERS IN IMMUNOLOGY, 2024, 15